Zag Bio

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Health and bioPear VC

Website: zagbio.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: biotech.

Stage: Series A.

Based in: Cambridge, United States.

On Recent Funding since: Sep 28, 2026.

Signals

Website registeredSep 30, 2022 (4 years old)

Timeline

September 30, 2022
Website created
Date unknown
PPear VC · accelerator or program
Source: pear.vc

Founders and team

AC
Alan Crane Co-Founder and Board Chair

source: zagbio.com
DM
Diane Mathis Founder
JV
Jo Viney Founder
JD
John D. Kulman Co-Founder

source: zagbio.com
JC
Jason Cole CEO

Investors

Companies like Zag Bio

AAbcuro$66M Series B+ · Aug 2026
IInnornaSeries B+ · Apr 2022
NNilo Therapeutics$101M Series A · Oct 2025
BBoulevard Bio$65M Seed · Aug 2026
PPretzel TherapeuticsSeries A · Sep 2022
NNewLimit$435M Series B+ · Jun 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/zag-bio (get a free API key).